TALi Digital (ASX:TD1) - Outgoing Managing Director & CEO, Glenn Smith
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • TALi Digital (TD1) announces Glenn Smith has resigned as Managing Director and CEO of the company, effective March 31
  • Mr Smith says his decision related to his desire to focus on other priorities
  • The board says it will undertake a search for a new CEO, and in the interim, TALi Digital Chair Sue MacLeman will take on the added responsibility
  • TD1 shares hold steady at 1.1 cents

Digital health company TALi Digital (TD1) has announced Glenn Smith has resigned as Managing Director and CEO of the company, effective March 31.

Mr Smith said his decision related to his desire to focus on other priorities.

“I am exceptionally proud of what my team and I have achieved this far and excited about what the future holds for the business,” said Mr Smith.

“Now is the right time for me to handover to the new executive team and importantly the outlook for the business is extremely positive.”

The board said it will undertake a search for a new CEO, and in the interim, TALi Digital Chair Sue MacLeman will take on the added responsibility.

Mr Smith had been in his role as MD since October 2017 and most recently helped the company raise funds to support the commercialisation and development of TALi products.

He previously had more than 20 years of experience in a variety of senior and executive roles, particularly in start-ups.

TD1 shares were steady at 1.1 cents as of 10:09 am AEDT.

TD1 by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Elixir pops as Neil Young steps down; US futures green & more

The local bourse traded green on Monday with IT in the lead up 2.6% led by…
Gold spot market concept

Macquarie puts the screws on Bellevue as $156.5M raise announced; job cuts to come

First and foremost, to call this a Bellevue Gold (ASX:BGL) led raise would perhaps be a distortion of the
The Market Online Video

Why most investors fail and how the top 20% succeed

This week on Money and Investing, Mitch Olarenshaw and I talk about why 80% of investors fail and what sets the top 20%
The Market Online Video

Neurizon Therapeutics announces strong safety results in latest study

Drug candidate NUZ-001 has shown strong safety characteristics in its latest human 3D brain model study, Neurizon Therapeutics (ASX:NUZ)